Atlas Trials

Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)

Clinical trial NCT03907605 · COMPLETED

Trial details

NCT number
NCT03907605
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Anti-Mullerian Hormone DeficiencyPost Partum Hemorrhage
Start date
2018-03-01
Primary completion
2019-03-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.